Delivery Order SPE2DB22D1202-SPE2DB24FVBF5

Award Date 5/22/24
Potential Completion Date 5/23/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp's Corporate Office division. The $10,247.98 firm-fixed-price delivery order is for the supply of 4565406441 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen, a large pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,792,365 units of the pharmaceutical product CLOBAZAM 10 MG TABLET 100S. The contract, valued at $6,599.62, has a completion date of June 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical through December 31, 2025. This single-award IDC serves as the primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $2,093.59 with a firm fixed price, and a completion date of January 7, 2025. The contract is for the delivery of 4566847098 - CLOBAZAM 10 MG TABLET 100S, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $1,555.93, is for the delivery of 4,564,739,430 units of the pharmaceutical product clobazam 10 mg tablets. The contract is a Firm Fixed Price Delivery Order and has a period of performance through May 30, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,796.51 Firm Fixed Price delivery order contract is for the supply of 4566848926 CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of 4,565,020,776 Clobazam 10 mg tablets in 100-count bottles. The contract has a ceiling value of $3,283.62 and a completion date of June 28, 2024. It was awarded on a full and open competition basis without any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) that serve as primary vehicles for providing...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $6,264.82 firm fixed price delivery order is for the supply of 4,564,340,522 units of the prescription medication clobazam 10 mg tablets. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.20 firm fixed-price delivery order is for the supply of 4566691271 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific...
This federal contract award of $9,728.52 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,074,533 units of the drug Clobazam 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of January 29, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVBF5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,690,861 CLOBAZAM 10 MG TABLET 100S to the Defense Logistics Agency (DLA). The ceiling value of the contract is $7,779.65, with a firm fixed price and an ultimate completion date of May 23, 2024.

Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 8/21/24, 7:41 PM